Improvements in mass spectrometry (MS)-based analytical throughput have been achieved using laser desorption ionization techniques (as in LDTD-96 and LDTD-384) and this has led to increased utility for this technology among research groups supporting early drug discovery efforts.
Lead discovery teams that perform high-throughput screening (HTS) assays intended to identify active compounds against therapeutic targets of interest will find the Phytronix LDTD presentation and exhibit at the San Diego SLAS Conference 2016 January 23-27 of particular interest. To learn more see www.slas2016.org/program/preliminaryprogram.cfm
Note: The Scientific Program is the cornerstone of SLAS2016.
Andrew Wagner, Bristol-Myers Squibb will present: Advances in Bioanalytics, Biomarkers and Diagnostics: Continuing the Quest for a Mass Spectrometry-Based Plate Reader: Evaluating Laser Diode Thermal Desorption (LDTD) coupled with Nanoliter Dispensing for HTS and HT-ADME Applications. January 25, Monday, 4-4:30 pm.
Stop by Phytronix Booth 752 to see the LDTD for yourself, or call Overbrook Scientific to learn more: 855-782-4373.